4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-011327
Chief Executive Officer sold 19,039 shares at $7.45 ($141,894)
- Chief Executive Officer acquired 285,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| De Backer Marianne Chief Executive Officer | 2026-02-22 | Grant or award 10b5-1 | +285,000 | 1,054,505 | D | ||
| De Backer Marianne Chief Executive Officer | 2026-02-23 | Sale 10b5-1 | −19,039 | $7.45 | $141,894 | 1,035,466 | D |
| Derivatives | |||||||
| De Backer Marianne Chief Executive Officer | 2026-02-22 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +570,000 | 570,000 | D | ||
| Open-market sales · 19,039 sh · avg $7.45 · $141,894 | |||||||
Loading xslF345X05/wk-form4_1771978165.xml…